How targeted therapies are boosting outcomes for bone marrow cancer
New Delhi, Sep 30 (IANS) Patients with chronic myeloid leukaemia (CML) — a type of cancer of the bone marrow — are seeing better outcomes with targeted therapies, said experts on Monday. CML is a slow-growing cancer that affects the bone marrow and blood. The US National Institute of Health (US) estimates that 1.2 to […]